These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35360784)

  • 1. COVID19 associated mucormycosis: A review.
    Palanisamy PR; Elango D
    J Family Med Prim Care; 2022 Feb; 11(2):418-423. PubMed ID: 35360784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rare Case of Mandibular Mucormycosis in a Post-COVID-19 Patient.
    Haidry N; Bhavana K; Shivhare P; Kumar V; Vaidyanathan A
    Cureus; 2022 Aug; 14(8):e28216. PubMed ID: 36158405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review.
    Upadhayay P; Bansal K; Goyal A
    Curr Pharm Biotechnol; 2023; 24(13):1645-1656. PubMed ID: 36941816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19.
    Sharma N; Wani SN; Behl T; Singh S; Zahoor I; Sehgal A; Bhatia S; Al-Harrasi A; Aleya L; Bungau S
    Environ Sci Pollut Res Int; 2023 Jan; 30(4):9164-9183. PubMed ID: 36454526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients: A tale of two pathogens.
    Sannathimmappa MB; Nambiar V; Aravindakshan R
    Int J Crit Illn Inj Sci; 2022; 12(1):38-46. PubMed ID: 35433396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycosis in COVID-19 pandemic: Risk factors and linkages.
    Kumar M; Sarma DK; Shubham S; Kumawat M; Verma V; Singh B; Nagpal R; Tiwari RR
    Curr Res Microb Sci; 2021 Dec; 2():100057. PubMed ID: 34396355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucormycosis, past and present: a comprehensive review.
    Gupta I; Baranwal P; Singh G; Gupta V
    Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series.
    Singh S; Basera P; Anand A; Ozair A
    Cureus; 2022 Aug; 14(8):e27906. PubMed ID: 36110469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucormycosis in COVID-19 patients.
    Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
    Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.
    Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ
    Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and Mucormycosis: A Black Fungus Disaster?
    Chillana S; Mohit Chilana KA
    Indian J Dermatol; 2022; 67(5):535-538. PubMed ID: 36865825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. As the virus sowed, the fungus reaped! A comparative analysis of the clinico-epidemiological characteristics of rhino-orbital mucormycosis before and during COVID-19 pandemic.
    Muraleedharan M; Panda NK; Angrish P; Arora K; Patro SK; Bansal S; Chakrabarti A; Rudramurthy SM; Bakshi J; Mohindra S; Gupta R; Virk RS; Verma RK; Ramavat AS; Nayak G
    Mycoses; 2022 May; 65(5):567-576. PubMed ID: 35289000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019.
    Al-Ani RM
    World J Virol; 2022 Sep; 11(5):293-299. PubMed ID: 36188746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of COVID with Mycosis in General.
    Kaur G; Kaur R; Sumanpreet ; Kaur M
    Infect Disord Drug Targets; 2024; 24(6):e190124225866. PubMed ID: 38251692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Uncommon Presentations of COVID-19-Associated Mucormycosis.
    Rathna R; D'Souza C; D'Silva C; Joseph JM; Varghese AK
    Cureus; 2022 Jan; 14(1):e21229. PubMed ID: 35186527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
    Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
    Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coincidence or reality behind Mucormycosis, diabetes mellitus and Covid-19 association: A systematic review.
    Sengupta I; Nayak T
    J Mycol Med; 2022 Aug; 32(3):101257. PubMed ID: 35219907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucormycosis in COVID Diabetic Patients: A Horrifying Triad!
    Panwar P; Gupta A; Kumar A; Gupta B; Navriya SC
    Indian J Crit Care Med; 2021 Nov; 25(11):1314-1317. PubMed ID: 34866832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.